Latest Regulatory News

Tetratherix Limited reported a $9.4 million statutory loss for FY25 amid significant R&D and operational investments, successfully listing on the ASX and progressing multiple clinical and manufacturing initiatives.

Micro-X Limited reported a $13.9 million loss for FY2025 as it pivots towards medical imaging, securing a landmark supply agreement with a major US healthcare provider for its Rover Plus mobile X-ray system.

Diatreme Resources has agreed to sell its Clermont Gold Project to Moonlight Resources as part of Moonlight’s upcoming ASX IPO, securing a significant equity stake and board representation.

Omni Bridgeway Limited reported a landmark FY25 with a $416.8 million net profit, driven by a transformative Fund 9 secondary market transaction that fully repaid debt and advanced its capital-light fund management model.

Moonlight Resources, partly owned by Lithium Plus Minerals, plans to acquire the Clermont Gold Project and pursue an ASX listing, aiming to become a focused gold and critical minerals explorer.

FOS Capital reported solid FY25 results, driven by organic growth and key acquisitions that expanded its market footprint and improved profitability. The company’s strategic moves position it well for continued consolidation in the fragmented lighting industry.

Zoono Group Limited has raised an additional A$992,000 through a shortfall placement, boosting its working capital to support global expansion of its shelf-life extension technology. The company also linked CEO share incentives to ambitious sales targets, signaling confidence in growth prospects.

Qantas Airways posted a robust FY25 financial performance with a 28% rise in statutory profit after tax, supported by strong travel demand and strategic fleet investments. The Group also announced substantial dividends and completed a $431 million share buy-back, while closing Jetstar Asia to focus on core markets.

Atlas Arteria’s half-year report for June 2025 reveals stable traffic and revenue growth across its French, German, and US toll road assets, underpinned by disciplined financial management and strategic capital investments.

TPG Telecom Limited has announced an ordinary unfranked dividend of AUD 0.09 per share for the six months ending June 2025, signaling steady shareholder returns without franking credits.

Atlas Arteria reported a 32.9% drop in statutory net profit for H1 2025 due to a new French tax, yet achieved solid toll revenue and EBITDA growth, maintaining its 2025 distribution guidance.

Atlas Arteria reported a statutory net profit of $73.3 million for H1 2025, impacted by a new tax, while toll revenues rose 8.1%. The company reaffirmed its 2025 distribution guidance of 40 cents per security, supported by strong free cash flow growth.